Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bellocq C, van Ginneken ACG, Bezzina CR, Alders M, Escande D, Mannens MMAM et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109(20):2394–2397
Hong K, Piper DR, Diaz-Valdecantos A, Brugada J, Oliva A, Burashnikov E et al (2005) De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 68(3):433–440
Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G (1996) K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384(6604):78–80
Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL et al (1996) Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384(6604):80–83
Courtemanche M, Ramirez RJ, Nattel S (1998) Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol 275(1 Pt 2):H301–H321
ten Tusscher KHWJ, Noble D, Noble PJ, Panfilov AV (2004) A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 286(4):H1573–H1589
Zhang H, Kharche S, Holden AV, Hancox JC (2008) Repolarization and vulnerability to re-entry in the human heart with short QT syndrome arising from KCNQ1 mutation–a simulation study. Prog Biophys Mol Biol 96(1–3):112–131
El Harchi A, McPate MJ, Zhang YH, Zhang H, Hancox JC (2010) Action potential clamp and mefloquine sensitivity of recombinant IKS channels incorporating the V307L KCNQ1 mutation. J Physiol Pharmacol 61(2):123–131
ten Tusscher KHWJ, Panfilov AV (2006) Alternans and spiral breakup in a human ventricular tissue model. Am J Physiol Heart Circ Physiol 291(3):H1088–H1100
Priebe L, Beuckelmann DJ (1998) Simulation study of cellular electric properties in heart failure. Circ Res 82(11):1206–1223
Silva J, Rudy Y (2005) Subunit interaction determines IKs participation in cardiac repolarization and repolarization reserve. Circulation 112(10):1384–1391
Rudy Y, Silva JR (2006) Computational biology in the study of cardiac ion channels and cell electrophysiology. Q Rev Biophys 39(1):57–116
Osteen JD, Sampson KJ, Kass RS (2010) The cardiac IKs channel, complex indeed. Proc Natl Acad Sci USA 107(44):18751–18752
Jespersen T, Grunnet M, Olesen S-P (2005) The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) 20:408–416
Cross B, Homoud M, Link M, Foote C, Garlitski A, Weinstock J et al (2011) The short QT syndrome. J Intervent Card Electrophysiol 31(1):25–31
Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94(2):99–102
Couderc J-P, Lopes CM (2010) Short and long QT syndromes: does QT length really matter? J Electrocardiol 43(5):396–399
Patel U, Pavri BB (2009) Short QT syndrome: a review. Cardiol Rev 17(6):300–303
Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P et al (2006) Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 27(20):2440–2447
Brugada R, Hong K, Cordeiro JM, Dumaine R (2005) Short QT syndrome. CMAJ 173(11):1349–1354
Gima K, Rudy Y (2002) Ionic current basis of electrocardiographic waveforms: a model study. Circ Res 90(8):889–896
Adeniran I, McPate MJW, Witchel HJ, Hancox JC, Zhang H (2011) Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 Short QT Syndrome. Plos Comput Biol 7(12):e1002313
Adeniran I, El Harchi A, Hancox JC, Zhang H (2012) Proarrhythmia in KCNJ2-linked short QT syndrome—insights from modelling. Cardiovasc Res 94(1):66–76
Yan GX, Shimizu W, Antzelevitch C (1998) Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation 98(18):1921–1927
Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H (1995) Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 26(1):185–192
Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96(7):800–807
Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M (2005) Short QT syndrome. Cardiovasc Res 67(3):357–366
Maury P, Extramiana F, Sbragia P, Giustetto C, Schimpf R, Duparc A et al (2008) Short QT syndrome, update on a recent entity. Arch Cardiovasc Dis 101(11–12):779–786
Schimpf R, Borggrefe M, Wolpert C (2008) Clinical and molecular genetics of the short QT syndrome. Curr Opin Cardiol 23(3):192–198
Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K et al (2010) High prevalence of early repolarization in short QT syndrome. Heart Rhythm 7(5):647–652
Hancox JC, McPate MJ, Harchi A, Duncan RS, Dempsey CE, Witchel HJ et al (2011) The Short QT syndrome. In: Tripathi ON, Ravens U, Sanguinetti MC (eds) Heart rate and rhythm (Internet). Springer, Heidelberg, pp 4–49 Available via DIALOG. http://www.springerlink.com/content/m8l86l8n3h81w43m/. Accessed 10 Jul 2011
Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U et al (2003) Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 14(12):1273–1277
Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2(4):416–417
Anttonen O, Junttila J, Giustetto C, Gaita F, Linna E, Karsikas M et al (2009) T-Wave morphology in short QT syndrome. Ann Noninvasive Electrocardiol 14(3):262–267
Bjerregaard P, Jahangir A, Gussak I (2006) Targeted therapy for short QT syndrome. Expert Opin Ther Targets 10(3):393–400
Duncan RS, McPate MJ, Ridley JM, Gao Z, James AF, Leishman DJ et al (2007) Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochem Pharmacol 74(3):425–437
Lerche C, Bruhova I, Lerche H, Steinmeyer K, Wei AD, Strutz-Seebohm N et al (2007) Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter. Mol Pharmacol 71(6):1503–1511
Billman GE (2010) Novel therapeutic targets for antiarrhythmic drugs, 1st edn. Wiley, New York
Towart R, Linders JTM, Hermans AN, Rohrbacher J, van der Linde HJ, Ercken M et al (2009) Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? J Pharmacol Toxicol Methods 60(1):1–10
Curtis MJ (2004) Is cardiac IKs a relevant drug target? Cardiovasc Res 61(4):651–652
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Adeniran, I. (2014). Mathematically Modelling the Functional Consequences of the SQT2 Mutation. In: Modelling the Short QT Syndrome Gene Mutations. Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-319-07200-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-07200-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07199-2
Online ISBN: 978-3-319-07200-5
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)